Antimicrobial type-II bacteriocins
View Patent ↗Computational systems and methods are described for identifying new type-ll bacteriocins using a systemic consensus formula and other related criteria. Newly identified type-ll bacteriocin peptides are tested experimentally and show potent microbicidal activities. Further provided are the sequences of Newly identified type-ll bacteriocin peptides, and a method of treating an infection in a patient in need thereof, comprising administering to the patient an effective amount of a peptide comprising an amino acid sequence disclosed.
1. An isolated peptide comprising an amino acid sequence selected from the group consisting of FKVIVTDAGHYPREWGKQLGKWIGSKIK (SEQ ID NO: 5), KRNYSIEKYVKNY1DFIKKAIDIFRPMPI (SEQ ID NO: 6), KTIATNATYYPNKWAKSAGKWIASKIK (SEQ ID NO: 7), and QYDKTGYKIGKTVGTIVRKGFEIWSIFK (SEQ ID NO: 8), wherein the peptide is not longer than 45 amino acid residues in length.
2. The isolated peptide of claim 1 , wherein the peptide has antimicrobial activity.
3. The isolated peptide of claim 1 , wherein the peptide is not longer than 40 amino acid residues in length.
4. The isolated peptide of claim 1 , wherein the peptide is not longer than 35 amino acid residues in length.
5. The peptide of claim 1 , comprising one or more non-natural amino acid residue.
6. The composition comprising the peptide claim 1 and a pharmaceutically acceptable carrier.
7. The composition of claim 6 , further comprising an antimicrobial agent.
8. The composition of claim 7 , wherein the antimicrobial agent is selected from the group consisting of imipenem, ceftazidime, colistin, chloroquine, artemisinin, vancomycin and daptomycin.
9. A method of treating an infection in a patient in need thereof, comprising administering to the patient an effective amount of the peptide of claim 1 comprising an amino acid sequence of Table 2 or 3 or SEQ ID NO:328 1884 or an amino acid derived from a sequence of Table 2 or 3 or SEQ ID NO:328 1884 with one amino acid substitution.
10. The method of claim 9 , wherein the infection is caused by a Gram-negative bacterium, a Gram-positive bacterium or a fungus.